408 related articles for article (PubMed ID: 17460282)
1. Activation of SRC kinases signals induction of posterior capsule opacification.
Walker JL; Wolff IM; Zhang L; Menko AS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2214-23. PubMed ID: 17460282
[TBL] [Abstract][Full Text] [Related]
2. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
3. The role of Src family kinases in cortical cataract formation.
Zhou J; Menko AS
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2293-300. PubMed ID: 12091430
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Src kinase induction of cortical cataract following exposure to stress: destabilization of cell-cell junctions.
Zhou J; Leonard M; Van Bockstaele E; Menko AS
Mol Vis; 2007 Jul; 13():1298-310. PubMed ID: 17679932
[TBL] [Abstract][Full Text] [Related]
5. Prevention of posterior capsular opacification through cyclooxygenase-2 inhibition.
Chandler HL; Barden CA; Lu P; Kusewitt DF; Colitz CM
Mol Vis; 2007 Apr; 13():677-91. PubMed ID: 17563718
[TBL] [Abstract][Full Text] [Related]
6. Lithium stabilizes the polarized lens epithelial phenotype and inhibits proliferation, migration, and epithelial mesenchymal transition.
Stump RJ; Lovicu FJ; Ang SL; Pandey SK; McAvoy JW
J Pathol; 2006 Oct; 210(2):249-57. PubMed ID: 16924593
[TBL] [Abstract][Full Text] [Related]
7. Transition between proliferation and differentiation for lens epithelial cells is regulated by Src family kinases.
Walker JL; Zhang L; Menko AS
Dev Dyn; 2002 Aug; 224(4):361-72. PubMed ID: 12203728
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag.
Wormstone IM; Tamiya S; Anderson I; Duncan G
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2301-8. PubMed ID: 12091431
[TBL] [Abstract][Full Text] [Related]
9. Effects of nuclear factor-kappaB small interfering RNA on posterior capsule opacification.
Park HY; Kim IT; Lee KM; Choi JS; Park MO; Joo CK
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4707-15. PubMed ID: 20375325
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of alphavbeta6 integrin, a potent TGF-beta1 activator, and posterior capsule opacification.
Sponer U; Pieh S; Soleiman A; Skorpik C
J Cataract Refract Surg; 2005 Mar; 31(3):595-606. PubMed ID: 15811751
[TBL] [Abstract][Full Text] [Related]
11. A study of human lens cell growth in vitro. A model for posterior capsule opacification.
Liu CS; Wormstone IM; Duncan G; Marcantonio JM; Webb SF; Davies PD
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):906-14. PubMed ID: 8603875
[TBL] [Abstract][Full Text] [Related]
12. Selenium functionalized intraocular lenses inhibit posterior capsule opacification in an ex vivo canine lens capsular bag assay.
Pot SA; Chandler HL; Colitz CM; Bentley E; Dubielzig RR; Mosley TS; Reid TW; Murphy CJ
Exp Eye Res; 2009 Nov; 89(5):728-34. PubMed ID: 19583956
[TBL] [Abstract][Full Text] [Related]
13. Lens cell survival after exposure to stress in the closed capsular bag.
Duncan G; Wang L; Neilson GJ; Wormstone IM
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2701-7. PubMed ID: 17525202
[TBL] [Abstract][Full Text] [Related]
14. Effects of dexamethasone on posterior capsule opacification-like changes in a rat lens explant model.
Mansfield KJ; Cerra A; Chamberlain CG
Mol Vis; 2004 Oct; 10():728-37. PubMed ID: 15480302
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors trichostatin A and vorinostat inhibit TGFβ2-induced lens epithelial-to-mesenchymal cell transition.
Xie L; Santhoshkumar P; Reneker LW; Sharma KK
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4731-40. PubMed ID: 24994865
[TBL] [Abstract][Full Text] [Related]
16. Posterior capsule opacification.
Wormstone IM; Wang L; Liu CS
Exp Eye Res; 2009 Feb; 88(2):257-69. PubMed ID: 19013456
[TBL] [Abstract][Full Text] [Related]
17. Lens cell targetting for gene therapy of prevention of posterior capsule opacification.
Malecaze F; Lubsen NH; Serre B; Decha A; Duboue M; Penary M; Berg D; Arnaud JD; Titeux M; Kremer EJ; Couderc B
Gene Ther; 2006 Oct; 13(19):1422-9. PubMed ID: 16724094
[TBL] [Abstract][Full Text] [Related]
18. Aldose Reductase Inhibition Prevents Development of Posterior Capsular Opacification in an In Vivo Model of Cataract Surgery.
Zukin LM; Pedler MG; Groman-Lupa S; Pantcheva M; Ammar DA; Petrash JM
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3591-3598. PubMed ID: 30025084
[TBL] [Abstract][Full Text] [Related]
19. [Lens fiber differentiation in rats posterior capsule opacification].
Huang YS; Xie LX
Zhonghua Yan Ke Za Zhi; 2007 Mar; 43(3):260-5. PubMed ID: 17605911
[TBL] [Abstract][Full Text] [Related]
20. Effect of TGF-beta2 and anti-TGF-beta2 antibody in a new in vivo rodent model of posterior capsule opacification.
Lois N; Taylor J; McKinnon AD; Smith GC; van't Hof R; Forrester JV
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4260-6. PubMed ID: 16249506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
